Rezultati - Max S Topp
- Showing 1 - 20 results of 69
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants od Georg Rauser, Hermann Einsele, Christian Sinzger, Dorothee Wernet, Gabriele Kuntz, Mario Assenmacher, John D. Campbell, Max S. Topp
Izdano 2003Artigo -
7
Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors od Anthony S. Stein, Gary J. Schiller, Ramsis Benjamin, Catherine Jia, Alicia Zhang, Min Zhu, Zachary Zimmerman, Max S. Topp
Izdano 2018Artigo -
8
The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78 od Leo Rasche, Johannes Duell, Charlotte Morgner, Manik Chatterjee, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein
Izdano 2013Artigo -
9
-
10
Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B Cells od Eisei Kondo, Max S. Topp, Hans‐Peter Kiem, Yuichi Obata, Yasuo Morishima, Kiyotaka Kuzushima, Mitsune Tanimoto, Mine Harada, Takashi Takahashi, Yoshiki Akatsuka
Izdano 2002Artigo -
11
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab od Max S. Topp, Zachary Zimmerman, Paul Cannell, Hervé Dombret, Johan Maertens, Anthony S. Stein, Janet Franklin, Qui Tran, Ze Cong, Andre C. Schuh
Izdano 2018Artigo -
12
Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL od Johannes Duell, Marcus Dittrich, Tanja Bedke, Tobias Mueller, Florian Eisele, Andreas Rosenwald, Leo Rasche, Elena Hartmann, Thomas Dandekar, Hermann Einsele, Max S. Topp
Izdano 2017Artigo -
13
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia od Hervé Dombret, Max S. Topp, Andre C. Schuh, Andrew H. Wei, Simon Durrant, Christopher Larry Bacon, Qui Tran, Zachary Zimmerman, Hagop M. Kantarjian
Izdano 2019Artigo -
14
GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 od Leo Rasche, Johannes Duell, Inês C. Castro, Valentina Dubljevic, Manik Chatterjee, Stefan Knop, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein
Izdano 2015Artigo -
15
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma od Bastian von Tresckow, Franck Morschhauser, Vincent Ribrag, Max S. Topp, Caly Chien, Shobha Seetharam, Regina Aquino, Sonja Kotoulek, Carla J. de Boer, Andreas Engert
Izdano 2015Artigo -
16
-
17
Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL od Virginie Nägele, Andrea Kratzer, Gerhard Zugmaier, Chris Holland, Youssef Hijazi, Max S. Topp, Nicola Gökbuget, Patrick A. Baeuerle, Peter Kufer, Andreas Wolf, Matthias Klinger
Izdano 2017Artigo -
18
-
19
Fibrin-associated large B-cell lymphoma arising in a cystic lymphangiomatous lesion of the adrenal gland: A case report and overview of the entity od Stefan Kircher, Julia Böck, Katja Maurus, Johannes Düll, Max S. Topp, Anna Katharina Seitz, Christian Kestler, Karen Ernestus, Ioannis Anagnostopoulos, Andreas Rosenwald, Elena Hartmann
Izdano 2025Revisão -
20
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation od Anthony S. Stein, Hagop M. Kantarjian, Nicola Gökbuget, Ralf C. Bargou, Mark R. Litzow, Alessandro Rambaldi, Josep‐María Ribera, Alicia Zhang, Zachary Zimmerman, Gerhard Zugmaier, Max S. Topp
Izdano 2019Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Oncology
Biology
Immunology
Leukemia
Refractory (planetary science)
Astrobiology
Blinatumomab
Lymphoblastic Leukemia
Gastroenterology
Chemotherapy
Lymphoma
Physics
Antigen
Transplantation
Genetics
Immune system
Immunotherapy
Minimal residual disease
Adverse effect
CD8
T cell
Biochemistry
Cytotoxic T cell
Hematopoietic stem cell transplantation
In vitro
Acute lymphocytic leukemia
Antibody
Cancer